These stocks are best positioned to benefit from a coming Covid-19 testing surge, Jefferies says
June 02, 2020 at 11:53 AM EDT
Expansion in U.S. Covid-19 testing capabilities will benefit a handful of companies and reveal a new, $60 billion market, Jefferies says.
